Racial-Ethnic Disparities in Ketamine and Esketamine Therapy for Major Depressive Disorder.
Psychiatric services (Washington, D.C.) June 25, 2025 Michael Liu, Rachel Branning, Austin Lee et al. 2 citations
This study sought to investigate racial-ethnic disparities in the utilization of intravenous ketamine and intranasal esketamine therapy for major depressive disorder. The TriNetX platform was used to identify 861,179 patients diagnosed as having moderate-to-severe recurrent major depressive disorder between January 2019 and October 2024. Patients were divided into non-Hispanic White,...